Astellas Pharma Total Liabilities and Share Holders Equity 2012-2024 | ALPMY

Astellas Pharma total liabilities and share holders equity for the quarter ending June 30, 2024 was $23.907B, a 13.95% increase year-over-year.

  • Astellas Pharma total liabilities and share holders equity for 2024 was $23.64B, a 27.99% increase from 2023.
  • Astellas Pharma total liabilities and share holders equity for 2023 was $18.47B, a 3.39% decline from 2022.
  • Astellas Pharma total liabilities and share holders equity for 2022 was $19.118B, a 6.66% decline from 2021.

Astellas Pharma Total Liabilities and Share Holders Equity 2012-2024 | ALPMY

  • Astellas Pharma total liabilities and share holders equity for 2024 was $23.64B, a 27.99% increase from 2023.
  • Astellas Pharma total liabilities and share holders equity for 2023 was $18.47B, a 3.39% decline from 2022.
  • Astellas Pharma total liabilities and share holders equity for 2022 was $19.118B, a 6.66% decline from 2021.